COLY – One analyst on the CC tired to get COLY to take the bait on using a DNDN-like excuse that immunotherapy takes a long time to ramp up. To their credit, management didn’t bite.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”